company background image
A032

Wonik KOSDAQ:A032940 Stock Report

Last Price

₩4.42k

Market Cap

₩82.7b

7D

-4.8%

1Y

-18.7%

Updated

24 May, 2022

Data

Company Financials
A032940 fundamental analysis
Snowflake Score
Valuation5/6
Future Growth0/6
Past Performance2/6
Financial Health4/6
Dividends0/6

A032940 Stock Overview

Wonik Corporation engages in the semiconductor, trade and distribution, finance, electric and electronics, and leisure businesses in South Korea.

Wonik Competitors

 

 

 

 

 

 

 

 

 

 

 

 

Price History & Performance

Summary of all time highs, changes and price drops for Wonik
Historical stock prices
Current Share Price₩4,415.00
52 Week High₩6,150.00
52 Week Low₩3,850.00
Beta1.22
1 Month Change-10.81%
3 Month Change2.91%
1 Year Change-18.69%
3 Year Change8.61%
5 Year Change-29.25%
Change since IPO-11.35%

Recent News & Updates

May 03
I Ran A Stock Scan For Earnings Growth And Wonik (KOSDAQ:032940) Passed With Ease

I Ran A Stock Scan For Earnings Growth And Wonik (KOSDAQ:032940) Passed With Ease

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...

Feb 21
Reflecting on Wonik's (KOSDAQ:032940) Share Price Returns Over The Last Five Years

Reflecting on Wonik's (KOSDAQ:032940) Share Price Returns Over The Last Five Years

While not a mind-blowing move, it is good to see that the Wonik Corporation ( KOSDAQ:032940 ) share price has gained...

Shareholder Returns

A032940KR HealthcareKR Market
7D-4.8%6.0%1.2%
1Y-18.7%-40.8%-14.3%

Return vs Industry: A032940 exceeded the KR Healthcare industry which returned -40.8% over the past year.

Return vs Market: A032940 underperformed the KR Market which returned -14.3% over the past year.

Price Volatility

Is A032940's price volatile compared to industry and market?
A032940 volatility
A032940 Average Weekly Movement3.3%
Healthcare Industry Average Movement6.0%
Market Average Movement5.4%
10% most volatile stocks in KR Market10.2%
10% least volatile stocks in KR Market3.1%

Stable Share Price: A032940 is less volatile than 75% of KR stocks over the past 3 months, typically moving +/- 3% a week.

Volatility Over Time: A032940's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
198191Cha Yikhttps://www.wonik.com

Wonik Corporation engages in the semiconductor, trade and distribution, finance, electric and electronics, and leisure businesses in South Korea. The company offers process devices building circuits on substrate boards; dry etcher in black plane and thin film encapsulation; thin film solar cell equipment; quartz ware products; ceramics; lamps; semiconductor precision cleaning equipment; precursor; gas supply, purification, and monitoring systems; precursor supply systems; and plumbing construction. It also trades in medical devices, such as beauty equipment, and surgical devices and instruments; industrial raw materials and lighting-related products; chemical products of paints, inks, adhesives, papers, artificial marble, electron materials, and synthetic leather and fabrics; engineered plastics and silicon products; building materials; lipid components; and commercial and industrial printing and printers, as well as offers related management education, technical support, software upgrade, and consumable parts.

Wonik Fundamentals Summary

How do Wonik's earnings and revenue compare to its market cap?
A032940 fundamental statistics
Market Cap₩82.69b
Earnings (TTM)₩28.49b
Revenue (TTM)₩94.67b

2.8x

P/E Ratio

0.8x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
A032940 income statement (TTM)
Revenue₩94.67b
Cost of Revenue₩52.52b
Gross Profit₩42.16b
Other Expenses₩13.67b
Earnings₩28.49b

Last Reported Earnings

Dec 31, 2021

Next Earnings Date

n/a

Earnings per share (EPS)1.57k
Gross Margin44.53%
Net Profit Margin30.09%
Debt/Equity Ratio16.3%

How did A032940 perform over the long term?

See historical performance and comparison

Valuation

Is Wonik undervalued compared to its fair value and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Below Fair Value

  • Significantly Below Fair Value

  • PE vs Industry

  • PE vs Market

  • PEG Ratio

  • PB vs Industry


37.4%

Undervalued compared to fair value

Share Price vs. Fair Value

Below Fair Value: A032940 (₩4415) is trading below our estimate of fair value (₩7053.09)

Significantly Below Fair Value: A032940 is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: A032940 is good value based on its Price-To-Earnings Ratio (2.8x) compared to the Asian Healthcare industry average (17.5x).

PE vs Market: A032940 is good value based on its Price-To-Earnings Ratio (2.8x) compared to the KR market (14.1x).


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate A032940's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: A032940 is good value based on its Price-To-Book Ratio (0.4x) compared to the KR Healthcare industry average (2.3x).


Future Growth

How is Wonik forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

Future Growth Score

0/6

Future Growth Score 0/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


16.6%

Forecasted Healthcare industry annual growth in earnings

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Wonik has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Past Performance

How has Wonik performed over the past 5 years?

Past Performance Score

2/6

Past Performance Score 2/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


14.6%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: A032940 has high quality earnings.

Growing Profit Margin: A032940's current net profit margins (30.1%) are lower than last year (90.7%).


Past Earnings Growth Analysis

Earnings Trend: A032940's earnings have grown by 14.6% per year over the past 5 years.

Accelerating Growth: A032940's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: A032940 had negative earnings growth (-64.1%) over the past year, making it difficult to compare to the Healthcare industry average (33.2%).


Return on Equity

High ROE: A032940's Return on Equity (13.2%) is considered low.


Financial Health

How is Wonik's financial position?

Financial Health Score

4/6

Financial Health Score 4/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Debt Coverage

  • Interest Coverage

Financial Position Analysis

Short Term Liabilities: A032940's short term assets (₩28.3B) do not cover its short term liabilities (₩39.4B).

Long Term Liabilities: A032940's short term assets (₩28.3B) do not cover its long term liabilities (₩60.4B).


Debt to Equity History and Analysis

Debt Level: A032940's net debt to equity ratio (12.8%) is considered satisfactory.

Reducing Debt: A032940's debt to equity ratio has reduced from 38.3% to 16.3% over the past 5 years.

Debt Coverage: A032940's debt is well covered by operating cash flow (23.2%).

Interest Coverage: A032940's interest payments on its debt are well covered by EBIT (7x coverage).


Balance Sheet


Dividend

What is Wonik current dividend yield, its reliability and sustainability?

Dividend Score

0/6

Dividend Score 0/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Future Dividend Coverage

Dividend Yield vs Market

Notable Dividend: Unable to evaluate A032940's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate A032940's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if A032940's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if A032940's dividend payments have been increasing.


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as A032940 has not reported any payouts.


Discover strong dividend paying companies

Management

How experienced are the management team and are they aligned to shareholders interests?


CEO

Cha Yik (62 yo)

10.67yrs

Tenure

Cha Dong Yik has been Chief Executive Officer of Wonik Corporation since September 30, 2011 and serves as its Managing Director. Cha Dong Yik serves as Director of Wonik Corporation. Cha Dong-Ik served as...


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Wonik Corporation's employee growth, exchange listings and data sources


Key Information

  • Name: Wonik Corporation
  • Ticker: A032940
  • Exchange: KOSDAQ
  • Founded: 1981
  • Industry: Health Care Distributors
  • Sector: Healthcare
  • Implied Market Cap: ₩82.688b
  • Shares outstanding: 18.19m
  • Website: https://www.wonik.com

Number of Employees


Location

  • Wonik Corporation
  • 20, Pangyo-ro
  • 255 beon-gil
  • Seongnam-si
  • Gyeonggi-do
  • South Korea

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/05/24 00:00
End of Day Share Price2022/05/24 00:00
Earnings2021/12/31
Annual Earnings2021/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.